Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human results demonstrate [64Cu]/[67Cu] to be a nearly ideal theranostic pair

June 25, 2019

Data reported from phase II study of pembrolizumab for recurrent respiratory papillomatosis

June 25, 2019

Results presented from first-in-human study of REGN-3767 against advanced malignancies

June 25, 2019

'Cheap and straightforward' structure predictions

June 25, 2019

FDA approves sBLA for Botox for pediatric patients with upper limb spasticity

June 25, 2019

Phase I/IIa trial of gB/pp65 CMV immunotherapeutic vaccine in recurrent glioblastoma

June 25, 2019

ROCK inhibition suppresses tumorigenesis in resistant CSCs

June 25, 2019

DGM1 as a novel biomarker of response to enzastaurin in DLBCL and glioblastoma

June 25, 2019

Gold nanoparticles found to improve CRISPR delivery system for gene editing

June 25, 2019

Gracell reports preliminary results from pilot study of GC-007F for B-ALL

June 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...